Financhill
Sell
27

CVRX Quote, Financials, Valuation and Earnings

Last price:
$7.28
Seasonality move :
30.72%
Day range:
$6.83 - $7.35
52-week range:
$5.81 - $18.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.22x
P/B ratio:
2.68x
Volume:
178.3K
Avg. volume:
446K
1-year change:
-52.8%
Market cap:
$190.6M
Revenue:
$51.3M
EPS (TTM):
-$2.69

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CVRX
CVRx
$12.3M -$0.57 36.28% -49.78% $16.83
IVF
INVO Fertility
$1.6M -- -- -- --
NMTC
NeuroOne Medical Technologies
-- -- 157.41% -57.14% --
NTRB
Nutriband
$710K -$0.13 73.79% -38.1% $13.00
NVNO
enVVeno Medical
-- -$0.34 -- -26.67% $16.50
SINT
SINTX Technologies
$725K -$0.71 20.07% -96.14% $30.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CVRX
CVRx
$7.32 $16.83 $190.6M -- $0.00 0% 3.22x
IVF
INVO Fertility
$2.39 -- $1.4M -- $0.00 0% 0.11x
NMTC
NeuroOne Medical Technologies
$0.62 -- $19.2M -- $0.00 0% 3.09x
NTRB
Nutriband
$6.88 $13.00 $76.4M -- $0.00 0% 34.11x
NVNO
enVVeno Medical
$3.00 $16.50 $52.6M -- $0.00 0% 275.41x
SINT
SINTX Technologies
$2.90 $30.00 $7.3M -- $0.00 0% 1.81x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CVRX
CVRx
40.95% 1.790 15.36% 10.70x
IVF
INVO Fertility
-- 3.433 -- --
NMTC
NeuroOne Medical Technologies
-- -0.602 -- 2.23x
NTRB
Nutriband
1.68% 3.138 0.28% 4.65x
NVNO
enVVeno Medical
-- 0.246 -- --
SINT
SINTX Technologies
0.82% 0.321 0.68% 1.91x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CVRX
CVRx
$12.8M -$10.3M -57.66% -89.85% -59.98% -$8.1M
IVF
INVO Fertility
-- -- -- -- -- --
NMTC
NeuroOne Medical Technologies
$1.9M $1.7M -238.93% -238.93% 64.45% $183.6K
NTRB
Nutriband
$191K -$1.4M -65.19% -69.58% -210.38% -$1.1M
NVNO
enVVeno Medical
-- -$6.7M -- -- -- -$5.1M
SINT
SINTX Technologies
$38K -$1.6M -146.19% -148.9% -875.52% -$1.3M

CVRx vs. Competitors

  • Which has Higher Returns CVRX or IVF?

    INVO Fertility has a net margin of -69.42% compared to CVRx's net margin of --. CVRx's return on equity of -89.85% beat INVO Fertility's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.24% -$0.43 $120.3M
    IVF
    INVO Fertility
    -- -- --
  • What do Analysts Say About CVRX or IVF?

    CVRx has a consensus price target of $16.83, signalling upside risk potential of 129.96%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 151.06%. Given that INVO Fertility has higher upside potential than CVRx, analysts believe INVO Fertility is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 1 0
    IVF
    INVO Fertility
    0 0 0
  • Is CVRX or IVF More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison INVO Fertility has a beta of 2.243, suggesting its more volatile than the S&P 500 by 124.267%.

  • Which is a Better Dividend Stock CVRX or IVF?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or IVF?

    CVRx quarterly revenues are $15.3M, which are larger than INVO Fertility quarterly revenues of --. CVRx's net income of -$10.7M is higher than INVO Fertility's net income of --. Notably, CVRx's price-to-earnings ratio is -- while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 3.22x versus 0.11x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    3.22x -- $15.3M -$10.7M
    IVF
    INVO Fertility
    0.11x -- -- --
  • Which has Higher Returns CVRX or NMTC?

    NeuroOne Medical Technologies has a net margin of -69.42% compared to CVRx's net margin of 54.53%. CVRx's return on equity of -89.85% beat NeuroOne Medical Technologies's return on equity of -238.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.24% -$0.43 $120.3M
    NMTC
    NeuroOne Medical Technologies
    58.85% $0.06 $2.9M
  • What do Analysts Say About CVRX or NMTC?

    CVRx has a consensus price target of $16.83, signalling upside risk potential of 129.96%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of -- which suggests that it could grow by 220.72%. Given that NeuroOne Medical Technologies has higher upside potential than CVRx, analysts believe NeuroOne Medical Technologies is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 1 0
    NMTC
    NeuroOne Medical Technologies
    0 0 0
  • Is CVRX or NMTC More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.671%.

  • Which is a Better Dividend Stock CVRX or NMTC?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or NMTC?

    CVRx quarterly revenues are $15.3M, which are larger than NeuroOne Medical Technologies quarterly revenues of $3.3M. CVRx's net income of -$10.7M is lower than NeuroOne Medical Technologies's net income of $1.8M. Notably, CVRx's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 3.22x versus 3.09x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    3.22x -- $15.3M -$10.7M
    NMTC
    NeuroOne Medical Technologies
    3.09x -- $3.3M $1.8M
  • Which has Higher Returns CVRX or NTRB?

    Nutriband has a net margin of -69.42% compared to CVRx's net margin of -211%. CVRx's return on equity of -89.85% beat Nutriband's return on equity of -69.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.24% -$0.43 $120.3M
    NTRB
    Nutriband
    29.58% -$0.12 $11.4M
  • What do Analysts Say About CVRX or NTRB?

    CVRx has a consensus price target of $16.83, signalling upside risk potential of 129.96%. On the other hand Nutriband has an analysts' consensus of $13.00 which suggests that it could grow by 88.95%. Given that CVRx has higher upside potential than Nutriband, analysts believe CVRx is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 1 0
    NTRB
    Nutriband
    1 0 0
  • Is CVRX or NTRB More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nutriband has a beta of 1.185, suggesting its more volatile than the S&P 500 by 18.545%.

  • Which is a Better Dividend Stock CVRX or NTRB?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or NTRB?

    CVRx quarterly revenues are $15.3M, which are larger than Nutriband quarterly revenues of $645.8K. CVRx's net income of -$10.7M is lower than Nutriband's net income of -$1.4M. Notably, CVRx's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 3.22x versus 34.11x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    3.22x -- $15.3M -$10.7M
    NTRB
    Nutriband
    34.11x -- $645.8K -$1.4M
  • Which has Higher Returns CVRX or NVNO?

    enVVeno Medical has a net margin of -69.42% compared to CVRx's net margin of --. CVRx's return on equity of -89.85% beat enVVeno Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.24% -$0.43 $120.3M
    NVNO
    enVVeno Medical
    -- -$0.30 --
  • What do Analysts Say About CVRX or NVNO?

    CVRx has a consensus price target of $16.83, signalling upside risk potential of 129.96%. On the other hand enVVeno Medical has an analysts' consensus of $16.50 which suggests that it could grow by 450%. Given that enVVeno Medical has higher upside potential than CVRx, analysts believe enVVeno Medical is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 1 0
    NVNO
    enVVeno Medical
    1 0 0
  • Is CVRX or NVNO More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.726%.

  • Which is a Better Dividend Stock CVRX or NVNO?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or NVNO?

    CVRx quarterly revenues are $15.3M, which are larger than enVVeno Medical quarterly revenues of --. CVRx's net income of -$10.7M is lower than enVVeno Medical's net income of -$6.2M. Notably, CVRx's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 3.22x versus 275.41x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    3.22x -- $15.3M -$10.7M
    NVNO
    enVVeno Medical
    275.41x -- -- -$6.2M
  • Which has Higher Returns CVRX or SINT?

    SINTX Technologies has a net margin of -69.42% compared to CVRx's net margin of -882.81%. CVRx's return on equity of -89.85% beat SINTX Technologies's return on equity of -148.9%.

    Company Gross Margin Earnings Per Share Invested Capital
    CVRX
    CVRx
    83.24% -$0.43 $120.3M
    SINT
    SINTX Technologies
    19.79% -$1.26 $3.9M
  • What do Analysts Say About CVRX or SINT?

    CVRx has a consensus price target of $16.83, signalling upside risk potential of 129.96%. On the other hand SINTX Technologies has an analysts' consensus of $30.00 which suggests that it could grow by 934.48%. Given that SINTX Technologies has higher upside potential than CVRx, analysts believe SINTX Technologies is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    CVRX
    CVRx
    5 1 0
    SINT
    SINTX Technologies
    1 1 0
  • Is CVRX or SINT More Risky?

    CVRx has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.821, suggesting its less volatile than the S&P 500 by 17.937%.

  • Which is a Better Dividend Stock CVRX or SINT?

    CVRx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CVRx pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CVRX or SINT?

    CVRx quarterly revenues are $15.3M, which are larger than SINTX Technologies quarterly revenues of $192K. CVRx's net income of -$10.7M is lower than SINTX Technologies's net income of -$1.7M. Notably, CVRx's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CVRx is 3.22x versus 1.81x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CVRX
    CVRx
    3.22x -- $15.3M -$10.7M
    SINT
    SINTX Technologies
    1.81x -- $192K -$1.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Sell
50
RGC alert for May 1

Regencell Bioscience Holdings [RGC] is up 20.58% over the past day.

Sell
38
WGS alert for May 1

GeneDx Holdings [WGS] is down 6.85% over the past day.

Sell
43
VICR alert for May 1

Vicor [VICR] is down 1.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock